Transformation of indolent B-cell lymphomas

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Histologic transformation (HT) to aggressive lymphoma is a known complication of indolent lymphomas, particularly follicular lymphoma to diffuse large B-cell lymphoma.
• The pathogenesis of HT remains largely unknown, with limited molecular insights translated into clinical practice.
• Despite advances like rituximab, HT presents diagnostic and therapeutic challenges in indolent lymphoma management.

Purpose of the Study:

• To review the current understanding of histologic transformation in indolent lymphomas.
• To highlight the diagnostic and management challenges associated with HT.
• To emphasize the need for further research and clinical trial incorporation.

Main Methods:

• Literature review and synthesis of existing data on histologic transformation in indolent lymphomas.
• Analysis of the impact of HT on patient prognosis and treatment strategies.
• Discussion of current challenges and future directions in HT research.

Main Results:

• Histologic transformation is a critical event in indolent lymphoma progression, impacting patient outcomes.
• Current diagnostic criteria and management strategies for HT are not fully established.
• Molecular underpinnings of HT are not well understood, hindering clinical advancements.

Conclusions:

• Histologic transformation remains a major challenge in indolent lymphoma care, necessitating improved understanding and management.
• Further research into HT pathogenesis and early detection is essential.
• Incorporating HT as a clinical endpoint in trials is vital for future progress.